PMID: 9187689Jun 1, 1997Paper

Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluation

Urology
B CampoG Ordesi

Abstract

This prospective study evaluated the clinical and urodynamic changes in patients with obstruction due to benign prostatic hyperplasia (BPH) treated with transurethral needle ablation (TUNA). One hundred twenty patients with obstructive uropathy due to BPH were treated with the TUNA procedure between January 1994 and December 1995. All patients were selected according to the criteria established by the guidelines proposed by the International Consensus Committee (World Health Organization, Paris, 1993). The TUNA procedure was performed in an outpatient setting using topical intraurethral anesthesia (2% lidocaine gel). Patients showed a decrease in irritative symptoms as measured by the international Prostate Symptom Score (IPSS) and postprocedure urodynamic parameters. The mean (+/- SD) pretreatment IPSS was 20.8 +/- 4.5. At 3 months, the IPSS decreased to 9.7 +/- 3.0 (108 patients) (P < 0.001). At 6 months it decreased to 6.8 +/- 3.1 (86 patients) and remained at 6.2 +/- 2.9 (72 patients) and 6.7 +/- 3.8 (42 patients) at 12 and 18 months, respectively (P < 0.001). At 1 year after treatment, the peak flow rate (Qmax) increased from 8.2 +/- 3.4 mL/s to 15.9 +/- 2.1 mL/s and was 14.1 +/- 2.5 mL/s at 18 months of follow-up (P < 0.0...Continue Reading

References

Apr 1, 1979·British Journal of Urology·P H Abrams, D J Griffiths

❮ Previous
Next ❯

Citations

Sep 17, 2009·Der Urologe. Ausg. A·R BergesUNKNOWN Society of German Urologists
Jul 22, 2006·World Journal of Urology·Sas Barmoshe, Alexandre R Zlotta
Mar 3, 2007·International Urology and Nephrology·Emerson Luís Zani, Nelson Rodrigues Netto
May 20, 1999·Journal of Cataract and Refractive Surgery·I S BarequetT P O'Brien
May 10, 2006·Prostate Cancer and Prostatic Diseases·C PatriarcaB Campo
Aug 13, 1999·International Journal of Urology : Official Journal of the Japanese Urological Association·K NamikiM Miki
Jan 26, 2000·Journal of Endourology·M A HolmesR M Chambers
Jul 27, 2001·Journal of Clinical Laser Medicine & Surgery·R J Lanzafame
Oct 13, 2006·Current Opinion in Urology·S MadersbacherM Marberger
Oct 13, 2006·Current Opinion in Urology·S A Macdiarmid
Dec 5, 2006·Current Opinion in Urology·Andrea TubaroRoberto Miano
May 16, 2006·The Journal of Urology·Hooman DjaladatGholamreza Pourmand
Dec 22, 1999·The Journal of Urology·R O RobertsM M Lieber
Mar 10, 2011·Cardiovascular and Interventional Radiology·Francisco C CarnevaleMiguel Srougi
Aug 2, 2013·Cardiovascular and Interventional Radiology·Francisco C Carnevale, Alberto A Antunes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.